Description

2-[8-(4-Chlorophenyl)-10-Oxa-7-Azabicyclo[4.4.0]Deca-2,4,7,11-Tetraen- 4-Yl]Propanoic Acid is a high-purity, complex heterocyclic compound featuring a bicyclic core structure with a chlorophenyl substituent and a propanoic acid functional group. This compound is valued for its role as a critical advanced pharmaceutical intermediate in the synthesis of novel active ingredients. It is primarily utilized by research institutions and manufacturers in the pharmaceutical and agrochemical sectors for the development of new therapeutic and crop protection agents.

Application

• Pharmaceutical Intermediate: Key building block in the research and synthesis of new drug candidates, particularly for central nervous system (CNS) or anti-inflammatory targets.
• Agrochemical Research: Serves as a precursor in the development of next-generation herbicides, fungicides, or insecticides.
• Chemical Synthesis: Used in organic chemistry research for constructing complex molecular architectures and studying structure-activity relationships (SAR).
• Material Science: Potential intermediate for specialty polymers or advanced organic materials requiring specific heterocyclic components.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects under cGMP conditions.

Basic Information

Product Name	2-[8-(4-Chlorophenyl)-10-Oxa-7-Azabicyclo[4.4.0]Deca-2,4,7,11-Tetraen- 4-Yl]Propanoic Acid
CAS No.	86818-29-3
Molecular Formula	C20H16ClNO3
Molecular Weight	353.80 g/mol
Synonyms	2-[8-(4-Chlorophenyl)-10-Oxa-7-Azabicyclo[4.4.0]deca-2,4,7,11-tetraen-4-yl]propanoic acid; 4-(1-Carboxyethyl)-8-(4-chlorophenyl)-10-oxa-7-azabicyclo[4.4.0]deca-2,4,7,11-tetraene; 8-(4-Chlorophenyl)-4-(1-carboxyethyl)-10-oxa-7-azabicyclo[4.4.0]deca-2,4,7,11-tetraene; Bicyclo[4.4.0]deca-2,4,7,11-tetraene propanoic acid derivative
EINECS	Contact for details

Quality Control

Our production of 2-[8-(4-Chlorophenyl)-10-Oxa-7-Azabicyclo[4.4.0]Deca-2,4,7,11-Tetraen- 4-Yl]Propanoic Acid adheres to stringent quality management systems. Every batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided with each shipment. We support development and commercial projects with material produced under quality standards appropriate for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Keep away from strong acids and incompatible organic solvents. For long-term storage, consider inert atmosphere conditions to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.